Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers

Azzurra Stefanucci, Wei Lei, Victor J. Hruby, Giorgia Macedonio, Grazia Luisi, Simone Carradori, John M. Streicher, Adriano Mollica

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Aim: The conjugation of fluorescent labels to opioid peptides is an extremely challenging task, which needs to be overcome to create new classes of probes for biological assays. Materials & methods: Three opioid peptide analogs of biphalin and [D-Pen2,5]-Enkephalin (DPDPE) containing a fluorescein-maleimide motif were synthesized. Results & discussion: The biphalin analog 17 binds to opioid receptors with Ki μ = 530 ± 90 nM and Ki δ = 69.8 ± 16.4 nM. We then tested the ability of the compounds to stimulate G-protein-coupling, 17 activated μ-receptor expressing cells (EC50 = 16.7 ± 6.7 nM, EMax = 76 ± 4%) as well as δ-receptor expressing cells (EC50 = 42 ± 10 nM, EMax = 34 ± 8%). However, 17 was not able to fluorescently label receptor in live or fixed cells. Conclusion: Our data suggest that the biphalin scaffold could be employed to develop fluorescent ligands with the appropriate fluorescent motif, and suggest a means for further probe development.

Original languageEnglish (US)
Pages (from-to)859-869
Number of pages11
JournalFuture Medicinal Chemistry
Volume9
Issue number9
DOIs
StatePublished - Jun 2017

Keywords

  • DPDPE
  • GPCRs
  • biphalin
  • fluorescein
  • fluorescent probes
  • opioid peptides

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers'. Together they form a unique fingerprint.

Cite this